

![]() |
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study |
|
Authors | ![]() | |
Published in | BMC Gastroenterology. 2012, vol. 12, 11 | |
Abstract | Hepatitis C decreases health related quality of life (HRQL) which is further diminished by antiviral therapy. HRQL improves after successful treatment. This trial explores the course of and factors associated with HRQL in patients given individualized or standard treatment based on early treatment response (Ditto-study). | |
Keywords | Adult — Age Factors — Aged — Antiviral Agents/therapeutic use — Dose-Response Relationship, Drug — Drug Therapy, Combination — Europe — Female — Health Surveys — Hepatitis C, Chronic/drug therapy — Humans — Interferon-alpha/therapeutic use — International Cooperation — Male — Middle Aged — Multivariate Analysis — Polyethylene Glycols/therapeutic use — Quality of Life — Recombinant Proteins/therapeutic use — Ribavirin/therapeutic use — Severity of Illness Index — Sex Characteristics — Treatment Outcome | |
Identifiers | PMID: 22292521 | |
Full text | ||
Structures | ||
Research group | Etudes et traitement de l'hépatite C et B (554) | |
Citation (ISO format) | BEZEMER, Geert et al. Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study. In: BMC Gastroenterology, 2012, vol. 12, p. 11. doi: 10.1186/1471-230X-12-11 https://archive-ouverte.unige.ch/unige:27535 |